Advanced search
Publication Cover
Current Medical Research and Opinion Volume 19, 2003 - Issue 4
Submit an article Journal homepage
83
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Clinical experience with the long-acting injectable formulation of the atypical antipsychotic, risperidone

Stephen D. Martin Professor and Consultant Psychiatrist, School of Sciences, Fleming Building, University of Sunderland, Sunderland SR1 3SD, UKCorrespondence[email protected]
,
Dr Susan E. Libretto Medical Writer and Publications Manager UK, Medical Department, Janssen-Cilag Ltd, Saunderton, High Wycombe, Buckinghamshire HP14 4HJ, UK
,
David J. Pratt Research Nurse, Briars Research Unit, Cherry Knowle Hospital, Ryhope, Sunderland SR2 0NB, UK
,
J. S. Brewin Consultant Psychiatrist, Queen's Medical Centre, University Hospital, Nottingham NG7 2UH, UK
,
Zahid-ul Huq Consultant Psychiatrist, Park Royal Centre for Mental Health, Central Middlesex Hospital, Acton Lane, London NW10 7NS, UK
&
B. T. Saleh Consultant Psychiatrist, Scunthorpe General Hospital, Cliff Gardens, Scunthorpe, Lincolnshire DN15 7BH, UK
Pages 298-305 | Accepted 23 Apr 2003, Published online: 22 Sep 2008

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Rogelio Apiquian, Rodrigo Córdoba & Mario Louzã. (2011) Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America. Neuropsychiatric Disease and Treatment 7, pages 19-26.
Read now
J. M. Olivares, J. Peuskens, J. Pecenak, S. Resseler, A. Jacobs & K. S. Akhras. (2009) Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry. Current Medical Research and Opinion 25:9, pages 2197-2206.
Read now
Meera Narasimhan, Chi Un Pae, Natasha Masand & Prakash Masand. (2007) Partial compliance with antipsychotics and its impact on patient outcomes. International Journal of Psychiatry in Clinical Practice 11:2, pages 102-111.
Read now
Ragnar Nesvåg & Lars Tanum. (2005) Therapeutic drug monitoring of patients on risperidone depot. Nordic Journal of Psychiatry 59:1, pages 51-55.
Read now

Articles from other publishers (12)

Artur Turek, Aleksandra Borecka, Henryk Janeczek, Michał Sobota & Janusz Kasperczyk. (2018) Formulation of delivery systems with risperidone based on biodegradable terpolymers. International Journal of Pharmaceutics 548:1, pages 159-172.
Crossref
Fleur M. Howells, David G. Kingdon & David S. Baldwin. (2017) Current and potential pharmacological and psychosocial interventions for anxiety symptoms and disorders in patients with schizophrenia: structured review. Human Psychopharmacology: Clinical and Experimental 32:5, pages e2628.
Crossref
Cinzia Guidali, Daniela Viganò, Stefania Petrosino, Erica Zamberletti, Natalia Realini, Giorgio Binelli, Tiziana Rubino, Vincenzo Di Marzo & Daniela Parolaro. (2010) Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine. The International Journal of Neuropsychopharmacology 14:01, pages 17-28.
Crossref
Rosa CatalánRafael Penadés. (2011) Risperidone Long-Acting Injection: Safety and Efficacy in Elderly Patients with Schizophrenia. Journal of Central Nervous System Disease 3, pages JCNSD.S4125.
Crossref
Daniela Vigano, Cinzia Guidali, Stefania Petrosino, Natalia Realini, Tiziana Rubino, Vincenzo Di Marzo & Daniela Parolaro. (2008) Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia. The International Journal of Neuropsychopharmacology 12:05, pages 599.
Crossref
Steven J. Siegel, Mary E. Dankert & Jennifer M. Phillips. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics 797 815 .
José M Olivares, Alfonso Rodriguez-Martinez, José A Burón, David Alonso-Escolano & Alexander Rodriguez-Morales. (2008) Cost-Effectiveness Analysis of Switching Antipsychotic Medication to Long-Acting Injectable Risperidone in Patients with Schizophrenia. Applied Health Economics and Health Policy 6:1, pages 41-53.
Crossref
Josè M. Olivares, Alfonso Rodriguez-Martinez, Josè A. Buron, David Alonso-Escolano & Alexander Rodriguez-Morales. (2013) Analisi costo-efficacia dello switch da un trattamento antipsicotico a risperidone iniettabile a rilascio prolungato in pazienti con schizofrenia. Giornale Italiano di Health Technology Assessment 1:1, pages 39-48.
Crossref
Soma Ganesan, Mario McKenna, Ric M. Procyshyn & Sheldon Zipursky. (2007) Risperidone long-acting injection in the treatment of schizophrenia spectrum illnesses: A retrospective chart review of 19 patients in the Vancouver Community Mental Health Organization (Vancouver, Canada). Current Therapeutic Research 68:6, pages 409-420.
Crossref
Pierre Chue & Robin Emsley. (2007) Long-Acting Formulations of Atypical Antipsychotics. CNS Drugs 21:6, pages 441-448.
Crossref
Kayla L. Metzger, Jody M. Shoemaker, Jonathan B. Kahn, Christina R. Maxwell, Yuling Liang, Jan Tokarczyk, Stephen J. Kanes, Meredith Hans, Anthony M. Lowman, Nily Dan, Karen I. Winey, Neal R. Swerdlow & Steven J. Siegel. (2006) Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits. Psychopharmacology 190:2, pages 201-211.
Crossref
W. Kissling, S. Heres, K. Lloyd, E. Sacchetti, P. Bouhours, R. Medori & P. M. Llorca. (2016) Direct transition to long-acting risperidone - analysis of long-term efficacy. Journal of Psychopharmacology 19:5_suppl, pages 15-21.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.